JIANGSU RECBIO TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.52 CNY | -5.33% |
|
-5.23% | -21.55% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 10,493 | 4,741 | 3,787 | - | - |
| Enterprise Value (EV) 1 | 9,450 | 4,741 | 4,366 | 4,879 | 4,828 |
| P/E ratio | -14.3 x | -8.29 x | -7.42 x | -7.86 x | -31.6 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | 13.4 x |
| EV / Revenue | - | - | - | - | 17 x |
| EV / EBITDA | -13.7 x | -7.75 x | -10.1 x | -12.6 x | -221 x |
| EV / FCF | -10,784,864 x | - | - | - | - |
| FCF Yield | -0% | - | - | - | - |
| Price to Book | 6.31 x | - | 7.6 x | 52.7 x | -79 x |
| Nbr of stocks (in thousands) | 482,963 | 480,319 | 479,152 | - | - |
| Reference price 2 | 21.73 | 9.871 | 7.903 | 7.903 | 7.903 |
| Announcement Date | 3/20/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | 283.6 |
| EBITDA 1 | - | -691.2 | -612 | -430.3 | -387.3 | -21.85 |
| EBIT 1 | - | -732.5 | -659.4 | -527.9 | -488.7 | -123.5 |
| Operating Margin | - | - | - | - | - | -43.54% |
| Earnings before Tax (EBT) 1 | - | -736 | -572.4 | -516.9 | -486.8 | -121.7 |
| Net income 1 | -657.6 | -722.7 | -572 | -516.6 | -486.5 | -121.5 |
| Net margin | - | - | - | - | - | -42.84% |
| EPS 2 | -1.560 | -1.520 | -1.190 | -1.065 | -1.005 | -0.2500 |
| Free Cash Flow | - | -876.3 | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 3/20/22 | 3/20/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 579 | 1,092 | 1,041 |
| Net Cash position 1 | - | 1,043 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -1.345 x | -2.82 x | -47.63 x |
| Free Cash Flow | - | -876 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | -43.3% | - | -73.9% | -332% | - |
| ROA (Net income/ Total Assets) | - | -34.2% | - | -29.5% | -20.4% | -12.5% |
| Assets 1 | - | 2,114 | - | 1,751 | 2,385 | 971.9 |
| Book Value Per Share 2 | - | 3.440 | - | 1.040 | 0.1500 | -0.1000 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 297 | - | 150 | 122 | 100 |
| Capex / Sales | - | - | - | - | - | 35.26% |
| Announcement Date | 3/20/22 | 3/20/23 | 3/20/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
7.903
CNY
Average target price
11.99
CNY
Spread / Average Target
+51.67%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.55% | 552M | |
| -2.47% | 90.28B | |
| -1.97% | 39.5B | |
| -15.47% | 31.71B | |
| +61.28% | 26.41B | |
| -22.81% | 14.34B | |
| -8.82% | 12.89B | |
| -11.77% | 11.8B | |
| -45.97% | 10.95B | |
| +3.30% | 8.85B |
- Stock Market
- Equities
- 2179 Stock
- Financials Jiangsu Recbio Technology Co., Ltd.
